期刊论文、会议论文

Clinical Study of KELONG Capsule in Treating Benign Prostatic Hyperplasia

中文

医学综述

1006-2084

2012

16

16

2545-2547

中华中医药学会亚健康分会换届选举会议暨第四次“治未病”及亚健康防治论坛

中华中医药学会亚健康分会换届选举会议暨第四次“治未病”及亚健康防治论坛论文集

2012-11-09

昆明

中华中医药学会

10.3969/j.issn.1006-2084.2010.16.056

本校为第一机构

　　目的：观察克癃胶囊治疗良性前列腺增生的有效性和安全性。方法：将240例BPH患者随机分组后分别给予相应治疗，疗程4周，分析比较试验组和对照组治疗前后中医症状、国际前列腺症状评分、最大尿流率、前列腺体积和剩余尿量等疗效指标变化差异，并作相应安全性评价.结果：两组中医证候疗效比较差异有统计学意义(P＜0.05).两组治疗后的国际前列腺症状评分、前列腺体积、最大尿流率和剩余尿量与治疗前比较，差异均有统计学意义(P＜0.01).治疗后两组的中医证侯积分、国际前列腺症状评分、最大尿流率比较差异均有统计学意义(P＜0.01或P＜0.05)；而前列腺体积、剩余尿量比较差异则无统计学意义(P＞...

Objective To observe effectiveness and safety of KELONG Capsule in treating benign prostatic hyperplasia（BPH）.Methods The 240 cases of BPH were randomly divided into two groups and with the appropriate four-week course of treatment respectively.The TCM symptoms,International Prostate Symptom Score（I-PSS）,maximum flow rate（Qmax）,prostate volume,residual urine（RU） and other efficacy indicators of the treatment group and the control group were analyzed and compared before and after treatment,the safety assessment was also made.Results Ther...